Best Stomach Cancer Treatment in Coimbatore

Stomach cancer in South Asia has a particularly troubling pattern: it is diagnosed later here than almost anywhere else in the world, and the reason is simple: persistent indigestion is accepted as a normal part of life. Too many patients arrive at oncology clinics with advanced disease that could have been caught and cured years earlier had a persistent stomach complaint been investigated with an endoscopy rather than managed with antacids indefinitely.

At GEM Cancer Centre in Coimbatore, our gastric oncology program is built around precision, surgical expertise, and the willingness to offer difficult procedures, including robotic gastrectomy and HIPEC, that require both training and experience. We provide the newest systemic therapies, including HER2-directed targeted therapy and immunotherapy for advanced gastric cancer. Patients across Tamil Nadu seeking stomach cancer treatment in Coimbatore will find a team that is honest about your situation, aggressive in treatment, and unwavering in support.

Understanding Stomach Cancer

Stomach cancer (gastric cancer) develops from the inner lining of the stomach, the mucosa, and most commonly takes the form of adenocarcinoma. These tumors are further classified by location (cardia versus non-cardia) and histological type (intestinal type versus diffuse type in the Lauren classification). Intestinal-type gastric cancer is associated with environmental factors, particularly H. pylori infection and diet, and is more responsive to HER2-targeted therapy. Diffuse-type cancer, including signet ring carcinoma, spreads through the stomach wall without forming a defined mass and requires different surgical and systemic strategies. Gastric cancer frequently spreads to the peritoneal lining (carcinomatosis), which is why HIPEC consideration forms part of surgical planning for locally advanced disease at GEM Cancer Centre.

Symptoms of Stomach Cancer

• Persistent indigestion or heartburn that doesn't respond to antacids.
• Discomfort or pain in the upper abdomen, especially after meals.
• Feeling abnormally full after eating only a small amount (early satiety).
• Nausea and occasional vomiting, sometimes with blood.
• Black, sticky, tarry stools indicating bleeding from the upper GI tract.
• Significant unintentional weight loss over weeks to months.
• Loss of appetite particularly concerning when new and progressive.
• Swallowing difficulty when the tumour involves the gastro-oesophageal junction.
• Iron-deficiency anaemia often the only sign detected on a routine blood test.

Diagnosis at GEM Cancer Centre

• Upper GI endoscopy with biopsy a definitive diagnostic tool chromoendoscopy with NBI improves early cancer detection.
• Endoscopic Ultrasound (EUS) assesses depth of tumour invasion through the stomach wall (T-staging).
• CT chest, abdomen, and pelvis regional lymphadenopathy, liver metastases, and peritoneal disease.
• PET-CT identifies distant metastases and peritoneal deposits that CT may miss.
• Diagnostic laparoscopy essential before committing to major surgery; identifies occult peritoneal metastases in 20–30% of patients thought to have resectable disease on CT.
• HER2 testing (IHC and FISH) is present in 15–20% of gastric cancers and predicts response to trastuzumab.
• MSI and PD-L1 testing identifies immunotherapy candidates.
• Blood tests CA 72-4, CEA, liver function, renal function, full blood count.

Treatment Options at GEM Cancer Centre

Robotic Gastrectomy with D2 Lymphadenectomy

Surgical resection, either subtotal or total gastrectomy, is the only potentially curative treatment for localized stomach cancer. GEM Cancer Centre performs robotic gastrectomy with D2 lymphadenectomy (the oncological standard removing all regional lymph nodes) through small incisions with 3D precision. Robotic D2 dissection reduces blood loss, minimizes the risk of injury to the pancreas and spleen, and allows for faster recovery.

Perioperative Chemotherapy (FLOT Protocol)

For resectable locally advanced gastric cancer, the FLOT regimen (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) given both before and after surgery significantly improves long-term survival compared to surgery alone.

HIPEC (Hyperthermic Intraperitoneal Chemotherapy)

When gastric cancer has spread to the peritoneum, conventional IV chemotherapy penetrates poorly. HIPEC combines cytoreductive surgery with heated chemotherapy at 42–43°C circulated inside the abdominal cavity, achieving remission and long-term survival in selected patients. GEM Cancer Centre is among the very few centers in Tamil Nadu offering this procedure.

Targeted Therapy: Trastuzumab and Trastuzumab Deruxtecan

For HER2-amplified gastric cancers, adding trastuzumab to platinum-fluoropyrimidine chemotherapy significantly improves survival. Trastuzumab deruxtecan (T-DXd) shows remarkable activity in HER2-positive and HER2-low metastatic disease.

Immunotherapy

Nivolumab combined with chemotherapy is now a standard first-line option for advanced gastric cancer. Pembrolizumab is approved for PD-L1-positive and MSI-high gastric cancers. The integration of immunotherapy has meaningfully extended survival for advanced gastric cancer patients.

Why Choose GEM Cancer Centre?

• Robotic gastrectomy with D2 lymphadenectomy the oncological standard performed minimally invasively
• HIPEC capability one of very few centres in Tamil Nadu offering this procedure.
• HER2, MSI, and PD-L1 testing guide personalized systemic therapy selection.
• Gastrointestinal tumour board weekly collective review before every treatment decision.
• Dedicated dietitian and nutritional rehabilitation support throughout treatment.
• H. pylori testing and eradication cancer prevention for high-risk patients.

When to See a Doctor

New-onset indigestion in a person above 50, especially combined with weight loss or appetite changes, should be investigated with endoscopy, not treated indefinitely with antacids. If your indigestion has persisted for more than 4–6 weeks despite medication, or if you have noticed dark stools, vomiting blood, or significant weight loss, contact GEM Cancer Centre without delay. These are not symptoms to manage conservatively.

Frequently Asked Questions